Below are the most recent publications written about "Exercise Tolerance" by people in Profiles.
-
McCartney KM, Edwards D, Pohlig R, Boyne P, Wright T, Wright H, Overstreet M, Reisman DS. Cardiopulmonary exercise tests in people with chronic stroke: Interpretation and clinical application. Clin Rehabil. 2025 Mar; 39(3):306-316.
-
Dharmavaram N, Esmaeeli A, Jacobson K, Brailovsky Y, Raza F. Cardiopulmonary Exercise Testing, Rehabilitation, and Exercise Training in Postpulmonary Embolism. Heart Fail Clin. 2025 Jan; 21(1):119-135.
-
Czulada E, Smith JD, Kolm P, Deb B, Dolman SF, Alexander N, Braun RA, Kabadi RA, Weintraub WS, Strouse D, Thomaides A. Rationale and Design of OPT-RATE AF: A Randomized Clinical Trial of Increased Physiologic Pacing Rates in Heart Failure With Preserved Ejection Fraction. Am J Cardiol. 2025 Jan 01; 234:1-8.
-
Braga F, Milani M, Espinosa G, Milani JGPO, Hansen D, Junior GC, Myers J, Mourilhe-Rocha R. Comparisons of percent-predicted peak oxygen uptake achieved on cardiopulmonary exercise testing: stratifying mortality risk by Wasserman, FRIEND, and Brazilian equations. Eur J Prev Cardiol. 2024 Oct 10; 31(14):1734-1737.
-
Corsi DR, Dikdan S, Upadhyay N, Chen H, Kitzman DW, Mentz R, Whellan DJ, Frisch DR. Atrial Fibrillation Status and Physical Rehabilitation in Older Patients With Acute Decompensated Heart Failure: An Analysis From the REHAB-HF Trial. J Am Heart Assoc. 2024 Oct; 13(19):e034366.
-
Tao R, Dharmavaram N, El Shaer A, Heffernan S, Tu W, Ma J, Garcia-Arango M, Baber A, Dhingra R, Runo J, Masri SC, Rahko P, Raza F. Relationship of TAPSE Normalized by Right Ventricular Area With Pulmonary Compliance, Exercise Capacity, and Clinical Outcomes. Circ Heart Fail. 2024 May; 17(5):e010826.
-
Psotka MA, Abraham WT, Fiuzat M, Filippatos G, Lindenfeld J, Ahmad T, Felker GM, Jacob R, Kitzman DW, Leifer ES, Lewis EF, Mentz RJ, Nkulikiyinka R, Ni W, Schaber DE, Sharma A, Solomon SD, Stockbridge N, Teerlink JR, Unger EF, Whellan DJ, Wittes J, Anker SD, O'Connor CM. Functional and Symptomatic Clinical?Trial?Endpoints: The HFC-ARC Scientific Expert Panel. JACC Heart Fail. 2022 12; 10(12):889-901.
-
Lewis GD, Voors AA, Cohen-Solal A, Metra M, Whellan DJ, Ezekowitz JA, Böhm M, Teerlink JR, Docherty KF, Lopes RD, Divanji PH, Heitner SB, Kupfer S, Malik FI, Meng L, Wohltman A, Felker GM. Effect of Omecamtiv Mecarbil on Exercise Capacity in Chronic Heart Failure With Reduced Ejection Fraction: The METEORIC-HF Randomized Clinical Trial. JAMA. 2022 07 19; 328(3):259-269.
-
Hegde SM, Lester SJ, Solomon SD, Michels M, Elliott PM, Nagueh SF, Choudhury L, Zemanek D, Zwas DR, Jacoby D, Wang A, Ho CY, Li W, Sehnert AJ, Olivotto I, Abraham TP. Effect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2021 12 21; 78(25):2518-2532.
-
Kobayashi Y, Christle JW, Contrepois K, Nishi T, Moneghetti K, Cauwenberghs N, Myers J, Kuznetsova T, Palaniappan L, Haddad F. Peripheral Oxygen Extraction and Exercise Limitation in Asymptomatic Patients with Diabetes Mellitus. Am J Cardiol. 2021 06 15; 149:132-139.